Lec 2 Social Acceptance of Medical Biotechnology
Lec 2 Social Acceptance of Medical Biotechnology
Lec 2 Social Acceptance of Medical Biotechnology
BIOTECHNOLOGY
SADIA DIN
HEALTH BIOTECHNOLOGY
SOCIAL ACCEPTANCE
Modern biotechnology has been viewed by many as the frontier of the next
revolution. It is a powerful tool that presents a range of potential environmental,
social and economic benefits that demands rigorous oversight.
However, because the advancement in biotechnology have been so rapid in the
past ten years, it has been the object of an intense and divisive debate in advanced
countries.
This suggest that a major factor in the emergence of controversies surrounding
biotechnology has been the neglect of the needs, interests and concerns of the
primary stakeholders the commoners.
Public perceptions, understanding and acceptance of GMOs can both promote and
hamper commercial introduction and adoption of new technologies
PUBLIC ACCEPTANCE OF VARIOU S APPLI-CATIONS OF
MODERN BIOTECHNOLOGY
Whilst there have been much debate on the acceptance of genetic engineering, there is many evidences
that objections to the technology focus on specific applications of the technology than genetic
engineering.
The consumer attitudes towards gene transfers are moderated by the type of transfers; plant to plant gene
transfers were generally more acceptable with animal-animal next, and animal-plant or human-animal
gene transfers the least acceptable.
According to a survey, Americans found out that medical applications (leading to the development of
medicines and vaccines and genetic testing) were more acceptable compared to food or crop
biotechnology applications.
The Asians were also less concerned about medical products of genetic engineering compared to
genetically modified food.
The highest level of support is found for bacteria to clean oil spills followed by disease resistant crops
next, and less fat meat and better taste tomatoes while there was less support for enhancing milk
production in cows.
CROSS-CULTURAL DIFFERENCES
The societal and individual risk perceptions are proportional to a system of moral values.
Individuals were willing to accept some level of risk if the product was deemed worthy and was not
morally objectionable.
Of the variables studied, usefulness, riskiness and morality, it was found that moral acceptability of
biotechnology was the strongest predictor of support for biotechnology.
Basic categories of moral or ethical concerns regarding modern biotechnology fall into two classes:
intrinsic and extrinsic (Comstock, 2000; Hamid, 2000).
Extrinsic objection refers to the concerns regarding the possible risks of different application of
biotechnology.
On the other hand, intrinsic objection allege that the process of modern biotechnology is objectionable
in itself.
This belief is associated with the unnaturalness claim, changing nature and to play ‘God”.
ISSUES REALATED TO BIOTECH
MEDICINE
PROTECTING HUMAN SUBJECTS IN CLINICAL TRIALS
This issue has generated considerable debate since 1999, when 18-year-old Jesse
Gelsinger died while participating in a gene therapy trial at the University of
Pennsylvania.
The institution was widely criticized for failing to disclose crucial information on
informed consent documents, relaxing criteria for accepting volunteers, and enrolling
volunteers who were ineligible.
The episode prompted a great deal of soul-searching among researchers and
regulators, and many universities began implementing new standards as a result of the
harsh spotlight that was cast on the clinical trial world.
AFFORDABILITY
Talk about a Pandora’s box. Protecting patient privacy is a growing concern, thanks to
technology that is making it possible to decode the human genome.
But as scientists become adept at deciphering a person’s genetic composition, it is
increasingly likely that compromising information about a person’s future health is
going to become available.
This creates enormous problems. For instance, it may become possible to know that a
5-year-old is going to develop serious heart disease later in life, but does a
prospective employer have the right to know that? How will this knowledge affect the
individual’s ability to obtain a job, insurance, or a mortgage? Should such information
be available to insurers and others? This is a thorny problem destined to become only
thornier.
STEM CELLS RESEARCH